{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:51:49Z","timestamp":1769248309505,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003061","name":"Erasmus MC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ijcard.2023.03.010","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T20:30:30Z","timestamp":1678221030000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease"],"prefix":"10.1016","volume":"380","author":[{"given":"L.E.","family":"Scheffers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.E.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.P.","family":"van den Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.I.","family":"van Capelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Helbing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9646","key":"10.1016\/j.ijcard.2023.03.010_bb0005","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet."},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2023.03.010_bb0010","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1007\/s10545-010-9179-2","article-title":"Antenatal diagnosis of pompe disease by fetal echocardiography: impact on outcome after early initiation of enzyme replacement therapy","volume":"33","author":"Hamdan","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ijcard.2023.03.010_bb0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2018.07.091","article-title":"Cardiac outcome in classic infantile Pompe disease after 13\u00a0years of treatment with recombinant human acid alpha-glucosidase","volume":"269","author":"van Capelle","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2023.03.010_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","article-title":"Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy","volume":"35","author":"van Gelder","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.010_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13023-020-01482-w","article-title":"Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients","volume":"15","author":"van den Dorpel","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ijcard.2023.03.010_bb0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ehjci\/jez041","article-title":"Myocardial strain imaging: review of general principles, validation, and sources of discrepancies","volume":"20","author":"Amzulescu","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2023.03.010_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2022.03.050","article-title":"Diagnosis and management of rare cardiomyopathies in adult and paediatric patients. A position paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP)","volume":"357","author":"Limongelli","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"25","key":"10.1016\/j.ijcard.2023.03.010_bb0040","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.ijcard.2023.03.010_bb0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10545-015-9912-y","article-title":"Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study","volume":"39","author":"van Gelder","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9227","key":"10.1016\/j.ijcard.2023.03.010_bb0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.ijcard.2023.03.010_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1047951118002378","article-title":"Reference values for two-dimensional myocardial strain echocardiography of the left ventricle in healthy children","volume":"29","author":"Koopman","year":"2019","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ijcard.2023.03.010_bb0060","series-title":"Echocardiography in Pediatric and Congenital Heart Disease. 2009; Echocardiography in Pediatric and Congenital Heart Disease","article-title":"Structural measurements and adjustment for growth","author":"Sluysmans","year":"2009"},{"key":"10.1016\/j.ijcard.2023.03.010_bb0065","series-title":"Echocardiography in Pediatric and Congenital Heart Disease","article-title":"Normal echocardiographic values for cardiovascular structures","author":"SD C","year":"2009"},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.010_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.echo.2010.09.018","article-title":"Assessment of myocardial deformation in children using digital imaging and Communications in Medicine (DICOM) data and vendor independent speckle tracking software","volume":"24","author":"Koopman","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.010_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2023.03.010_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12947-015-0029-0","article-title":"Normal ranges of left ventricular strain in children: a meta-analysis","volume":"13","author":"Jashari","year":"2015","journal-title":"Cardiovasc. Ultrasound"},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.010_bb0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2352-4642(21)00308-4","article-title":"Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe consortium","volume":"6","author":"Ditters","year":"2022","journal-title":"Lancet Child. Adolesc. Health"},{"issue":"6","key":"10.1016\/j.ijcard.2023.03.010_bb0090","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jimd.12268","article-title":"Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patients","volume":"43","author":"Poelman","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ijcard.2023.03.010_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/echo.13490","article-title":"Cardiac response to enzyme replacement therapy in infantile Pompe disease with severe hypertrophic cardiomyopathy","volume":"34","author":"Avula","year":"2017","journal-title":"Echocardiography."},{"issue":"6","key":"10.1016\/j.ijcard.2023.03.010_bb0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00246-008-9267-3","article-title":"Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease","volume":"29","author":"Levine","year":"2008","journal-title":"Pediatr. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2023.03.010_bb0105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cardfail.2011.07.011","article-title":"Left ventricular geometry, global function, and dyssynchrony in infants and children with pompe cardiomyopathy undergoing enzyme replacement therapy","volume":"17","author":"Chen","year":"2011","journal-title":"J. Card. Fail."},{"issue":"8","key":"10.1016\/j.ijcard.2023.03.010_bb0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.116.025795","article-title":"Ejection fraction: misunderstood and overrated (changing the paradigm in categorizing heart failure)","volume":"135","author":"Konstam","year":"2017","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.ijcard.2023.03.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2011.12.018","article-title":"Interaction between myocardial and vascular changes in obese children: a pilot study","volume":"25","author":"Koopman","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"6","key":"10.1016\/j.ijcard.2023.03.010_bb0120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10545-018-0166-3","article-title":"Long-term follow-up of 17 patients with childhood Pompe disease treated with enzyme replacement therapy","volume":"41","author":"van der Meijden","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.010_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ijcard.2023.03.010_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.010_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.ijcard.2023.03.010_bb0140","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/hmg\/7.11.1815","article-title":"Recombinant human acid alpha-glucosidase: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ijcard.2023.03.010_bb0145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI115025","article-title":"Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice","volume":"87","author":"Van der Ploeg","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ijcard.2023.03.010_bb0150","first-page":"723","article-title":"Quantitation of Mr 46000 and Mr 300000 mannose 6-phosphate receptors in human cells and tissues","volume":"23","author":"Wenk","year":"1991","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ijcard.2023.03.010_bb0155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2018.07.091","article-title":"Cardiac outcome in classic infantile Pompe disease after 13years of treatment with recombinant human acid alpha-glucosidase","volume":"269","author":"van Capelle","year":"2018","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323003388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323003388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:00:16Z","timestamp":1759093216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323003388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"alternative-id":["S0167527323003388"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.010","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}